ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 114 filers reported holding ATHIRA PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $762,944 | -49.5% | 377,695 | -26.3% | 0.00% | – |
| Q2 2023 | $1,512,128 | -24.2% | 512,586 | -35.7% | 0.00% | – |
| Q1 2023 | $1,993,646 | -39.3% | 797,458 | -23.1% | 0.00% | – |
| Q4 2022 | $3,285,924 | +22.7% | 1,036,569 | +15.0% | 0.00% | – |
| Q3 2022 | $2,677,000 | -54.8% | 901,281 | -53.6% | 0.00% | -100.0% |
| Q2 2022 | $5,923,000 | -67.5% | 1,941,787 | +43.8% | 0.00% | -50.0% |
| Q1 2022 | $18,233,000 | +35.5% | 1,350,587 | +30.8% | 0.00% | +33.3% |
| Q4 2021 | $13,452,000 | +16.2% | 1,032,437 | -16.3% | 0.00% | +50.0% |
| Q3 2021 | $11,575,000 | -13.5% | 1,233,949 | -5.5% | 0.00% | -33.3% |
| Q2 2021 | $13,377,000 | -42.4% | 1,306,406 | +3.4% | 0.00% | -50.0% |
| Q1 2021 | $23,240,000 | -41.6% | 1,263,070 | +8.8% | 0.01% | -40.0% |
| Q4 2020 | $39,770,000 | +99.8% | 1,161,158 | +7.7% | 0.01% | +66.7% |
| Q3 2020 | $19,900,000 | – | 1,078,015 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 714,763 | $2,265,799 | 2.16% |
| Perceptive Advisors | 4,797,278 | $15,207,371 | 0.43% |
| Potomac Capital Management, Inc. | 80,000 | $254 | 0.30% |
| Bristlecone Advisors, LLC | 696,629 | $2,208,314 | 0.27% |
| TANG CAPITAL MANAGEMENT LLC | 485,234 | $1,538,192 | 0.22% |
| RA Capital Management | 1,881,300 | $5,963,721 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 270,989 | $859 | 0.11% |
| PATHSTONE FAMILY OFFICE, LLC | 3,631,080 | $8,182,650 | 0.07% |
| Laird Norton Wetherby Trust Company, LLC | 130,000 | $412,100 | 0.06% |
| Forefront Analytics, LLC | 22,350 | $70,851 | 0.04% |